Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?
Buzzetti R, Galici V, Cirilli N, Majo F, Graziano L, Costa S, Bonacina S, Carrubba M, Davì G, Gagliano S, Cazzarolli C, Ficili F, Alghisi F, Samaja M, Magazzù G; CF Italian Patient Centered Outcomes Research Working Group (IPaCOR). Buzzetti R, et al. Among authors: alghisi f. J Cyst Fibros. 2019 May;18(3):378-381. doi: 10.1016/j.jcf.2018.02.009. Epub 2018 Mar 16. J Cyst Fibros. 2019. PMID: 29551462 Free article.
Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis.
Sofia VM, Surace C, Terlizzi V, Da Sacco L, Alghisi F, Angiolillo A, Braggion C, Cirilli N, Colombo C, Di Lullo A, Padoan R, Quattrucci S, Raia V, Tuccio G, Zarrilli F, Tomaiuolo AC, Novelli A, Lucidi V, Lucarelli M, Castaldo G, Angioni A. Sofia VM, et al. Among authors: alghisi f. Mol Med. 2018 Jul 27;24(1):38. doi: 10.1186/s10020-018-0041-6. Mol Med. 2018. PMID: 30134826 Free PMC article.
Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study.
Colombo C, Alicandro G, Oliver M, Lewindon PJ, Ramm GA, Ooi CY, Alghisi F, Kashirskaya N, Kondratyeva E, Corti F, Padoan R, Asherova I, Evans H, de Monestrol I, Strandvik B, Lindblad A; CF UDCA study group. Colombo C, et al. Among authors: alghisi f. J Cyst Fibros. 2022 Mar;21(2):220-226. doi: 10.1016/j.jcf.2021.03.014. Epub 2021 Apr 2. J Cyst Fibros. 2022. PMID: 33814323 Free article.
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.
Colombo C, Cipolli M, Daccò V, Medino P, Alghisi F, Ambroni M, Badolato R, Battistini F, Bignamini E, Casciaro R, Ciciriello F, Collura M, Comello I, Francalanci M, Ficili F, Folino A, Leonardi S, Leonetti G, Lucanto MC, Lucca F, Maschio M, Mencarini V, Messore B, Pisi G, Pizzamiglio G, Poli P, Raia V, Riberi L, Ros M, Rotolo N, Sepe A, Taccetti G, Vitullo P, Alicandro G. Colombo C, et al. Among authors: alghisi f. Infection. 2022 Jun;50(3):671-679. doi: 10.1007/s15010-021-01737-z. Epub 2021 Dec 7. Infection. 2022. PMID: 34874541 Free PMC article.
Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators.
Colombo C, Ramm GA, Lindblad A, Corti F, Porcaro L, Alghisi F, Asherova I, Evans H, Kashirskaya N, Kondratyeva E, Lewindon PJ, de Monestrol I, Oliver M, Ooi CY, Padoan R, Shankar S, Alicandro G. Colombo C, et al. Among authors: alghisi f. J Cyst Fibros. 2023 Mar;22(2):263-265. doi: 10.1016/j.jcf.2023.01.012. Epub 2023 Feb 2. J Cyst Fibros. 2023. PMID: 36739240
47 results